Global Gene Therapy Market Growth (Status and Outlook) 2021-2026

  • receipt Report ID : 159606
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 115
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Gene Therapy will have significant change from previous year. By the most conservative estimates of global Gene Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Gene Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Ex vivo

In Vivo

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Cancer

Monogenic

Infectious Disease

Cardiovascular Disease

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Bluebird Bio

Sangamo

Spark Therapeutics

Dimension Therapeutics

Avalanche Bio

Celladon

Vical Inc.

Advantagene

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gene Therapy Market Size 2016-2026

2.1.2 Gene Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Gene Therapy Segment by Type

2.2.1 Ex vivo

2.2.2 Ex vivo

2.3 Gene Therapy Market Size by Type

2.3.1 Global Gene Therapy Market Size CAGR by Type

2.3.2 Global Gene Therapy Market Size Market Share by Type (2016-2021)

2.4 Gene Therapy Segment by Application

2.4.1 Cancer

2.4.2 Monogenic

2.4.3 Infectious Disease

2.4.4 Cardiovascular Disease

2.4.5 Other

2.5 Gene Therapy Market Size by Application

2.5.1 Global Gene Therapy Market Size CAGR by Application

2.5.2 Global Gene Therapy Market Size Market Share by Application (2016-2021)

3 Global Gene Therapy by Players

3.1 Gene Therapy Market Size Market Share by Players

3.1.1 Global Gene Therapy Revenue by Players (2019-2021E)

3.1.2 Global Gene Therapy Revenue Market Share by Players (2019-2021E)

3.2 Global Gene Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Gene Therapy by Regions

4.1 Gene Therapy Market Size by Regions (2016-2021)

4.2 Americas Gene Therapy Market Size Growth (2016-2021)

4.3 APAC Gene Therapy Market Size Growth (2016-2021)

4.4 Europe Gene Therapy Market Size Growth (2016-2021)

4.5 Middle East & Africa Gene Therapy Market Size Growth (2016-2021)

5 Americas

5.1 Americas Gene Therapy Market Size by Country (2016-2021)

5.2 Americas Gene Therapy Market Size by Type (2016-2021)

5.3 Americas Gene Therapy Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gene Therapy Market Size by Region (2016-2021)

6.2 APAC Gene Therapy Market Size by Type (2016-2021)

6.3 APAC Gene Therapy Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Gene Therapy by Country (2016-2021)

7.2 Europe Gene Therapy Market Size by Type (2016-2021)

7.3 Europe Gene Therapy Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gene Therapy by Region (2016-2021)

8.2 Middle East & Africa Gene Therapy Market Size by Type (2016-2021)

8.3 Middle East & Africa Gene Therapy Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Gene Therapy Market Forecast

10.1 Global Gene Therapy Forecast by Regions (2021-2026)

10.1.1 Global Gene Therapy Forecast by Regions (2021-2026)

10.1.2 Americas Gene Therapy Forecast

10.1.3 APAC Gene Therapy Forecast

10.1.4 Europe Gene Therapy Forecast

10.1.5 Middle East & Africa Gene Therapy Forecast

10.2 Americas Gene Therapy Forecast by Countries (2021-2026)

10.2.1 United States Gene Therapy Market Forecast

10.2.2 Canada Gene Therapy Market Forecast

10.2.3 Mexico Gene Therapy Market Forecast

10.2.4 Brazil Gene Therapy Market Forecast

10.3 APAC Gene Therapy Forecast by Region (2021-2026)

10.3.1 China Gene Therapy Market Forecast

10.3.2 Japan Gene Therapy Market Forecast

10.3.3 Korea Gene Therapy Market Forecast

10.3.4 Southeast Asia Gene Therapy Market Forecast

10.3.5 India Gene Therapy Market Forecast

10.3.6 Australia Gene Therapy Market Forecast

10.4 Europe Gene Therapy Forecast by Country (2021-2026)

10.4.1 Germany Gene Therapy Market Forecast

10.4.2 France Gene Therapy Market Forecast

10.4.3 UK Gene Therapy Market Forecast

10.4.4 Italy Gene Therapy Market Forecast

10.4.5 Russia Gene Therapy Market Forecast

10.5 Middle East & Africa Gene Therapy Forecast by Region (2021-2026)

10.5.1 Egypt Gene Therapy Market Forecast

10.5.2 South Africa Gene Therapy Market Forecast

10.5.3 Israel Gene Therapy Market Forecast

10.5.4 Turkey Gene Therapy Market Forecast

10.5.5 GCC Countries Gene Therapy Market Forecast

10.6 Global Gene Therapy Forecast by Type (2021-2026)

10.8 Global Gene Therapy Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Bluebird Bio

11.1.1 Bluebird Bio Company Information

11.1.2 Bluebird Bio Gene Therapy Product Offered

11.1.3 Bluebird Bio Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Bluebird Bio Main Business Overview

11.1.5 Bluebird Bio Latest Developments

11.2 Sangamo

11.2.1 Sangamo Company Information

11.2.2 Sangamo Gene Therapy Product Offered

11.2.3 Sangamo Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Sangamo Main Business Overview

11.2.5 Sangamo Latest Developments

11.3 Spark Therapeutics

11.3.1 Spark Therapeutics Company Information

11.3.2 Spark Therapeutics Gene Therapy Product Offered

11.3.3 Spark Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Spark Therapeutics Main Business Overview

11.3.5 Spark Therapeutics Latest Developments

11.4 Dimension Therapeutics

11.4.1 Dimension Therapeutics Company Information

11.4.2 Dimension Therapeutics Gene Therapy Product Offered

11.4.3 Dimension Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Dimension Therapeutics Main Business Overview

11.4.5 Dimension Therapeutics Latest Developments

11.5 Avalanche Bio

11.5.1 Avalanche Bio Company Information

11.5.2 Avalanche Bio Gene Therapy Product Offered

11.5.3 Avalanche Bio Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Avalanche Bio Main Business Overview

11.5.5 Avalanche Bio Latest Developments

11.6 Celladon

11.6.1 Celladon Company Information

11.6.2 Celladon Gene Therapy Product Offered

11.6.3 Celladon Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Celladon Main Business Overview

11.6.5 Celladon Latest Developments

11.7 Vical Inc.

11.7.1 Vical Inc. Company Information

11.7.2 Vical Inc. Gene Therapy Product Offered

11.7.3 Vical Inc. Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Vical Inc. Main Business Overview

11.7.5 Vical Inc. Latest Developments

11.8 Advantagene

11.8.1 Advantagene Company Information

11.8.2 Advantagene Gene Therapy Product Offered

11.8.3 Advantagene Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Advantagene Main Business Overview

11.8.5 Advantagene Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Gene Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Ex vivo

Table 3. Major Players of In Vivo

Table 4. Gene Therapy Market Size CAGR by Type (2016-2021) & ($ Millions)

Table 5. Global Gene Therapy Market Size by Type (2016-2021) & ($ Millions)

Table 6. Global Gene Therapy Market Size Market Share by Type (2016-2021)

Table 7. Gene Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 8. Global Gene Therapy Market Size by Application (2016-2021) & ($ Millions)

Table 9. Global Gene Therapy Market Size Market Share by Application (2016-2021)

Table 10. Global Gene Therapy Revenue by Players (2019-2021E) & ($ Millions)

Table 11. Global Gene Therapy Revenue Market Share by Players (2019-2021E)

Table 12. Global Gene Therapy Key Players Head office and Products Offered

Table 13. Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Gene Therapy Market Size by Regions 2016-2021 & ($ Millions)

Table 17. Global Gene Therapy Market Size Market Share by Regions 2016-2021

Table 18. Americas Gene Therapy Market Size by Country (2016-2021) & ($ Millions)

Table 19. Americas Gene Therapy Market Size Market Share by Country (2016-2021)

Table 20. Americas Gene Therapy Market Size by Type (2016-2021) & ($ Millions)

Table 21. Americas Gene Therapy Market Size Market Share by Type (2016-2021)

Table 22. Americas Gene Therapy Market Size by Application (2016-2021) & ($ Millions)

Table 23. Americas Gene Therapy Market Size Market Share by Application (2016-2021)

Table 24. APAC Gene Therapy Market Size by Region (2016-2021) & ($ Millions)

Table 25. APAC Gene Therapy Market Size Market Share by Region (2016-2021)

Table 26. APAC Gene Therapy Market Size by Type (2016-2021) & ($ Millions)

Table 27. APAC Gene Therapy Market Size Market Share by Type (2016-2021)

Table 28. APAC Gene Therapy Market Size by Application (2016-2021) & ($ Millions)

Table 29. APAC Gene Therapy Market Size Market Share by Application (2016-2021)

Table 30. Europe Gene Therapy Market Size by Country (2016-2021) & ($ Millions)

Table 31. Europe Gene Therapy Market Size Market Share by Country (2016-2021)

Table 32. Europe Gene Therapy Market Size by Type (2016-2021) & ($ Millions)

Table 33. Europe Gene Therapy Market Size Market Share by Type (2016-2021)

Table 34. Europe Gene Therapy Market Size by Application (2016-2021) & ($ Millions)

Table 35. Europe Gene Therapy Market Size Market Share by Application (2016-2021)

Table 36. Middle East & Africa Gene Therapy Market Size by Region (2016-2021) & ($ Millions)

Table 37. Middle East & Africa Gene Therapy Market Size Market Share by Region (2016-2021)

Table 38. Middle East & Africa Gene Therapy Market Size by Type (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Gene Therapy Market Size Market Share by Type (2016-2021)

Table 40. Middle East & Africa Gene Therapy Market Size by Application (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Gene Therapy Market Size Market Share by Application (2016-2021)

Table 42. Key and Potential Regions of Gene Therapy

Table 43. Key Application and Potential Industries of Gene Therapy

Table 44. Key Challenges of Gene Therapy

Table 45. Key Trends of Gene Therapy

Table 46. Global Gene Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 47. Global Gene Therapy Market Size Market Share Forecast by Regions

Table 48. Global Gene Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 49. Global Gene Therapy Market Size Market Share Forecast by Type (2021-2026)

Table 50. Global Gene Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 51. Global Gene Therapy Market Size Market Share Forecast by Application (2021-2026)

Table 52. Bluebird Bio Details, Company Type, Gene Therapy Area Served and Its Competitors

Table 53. Bluebird Bio Gene Therapy Product Offered

Table 54. Bluebird Bio Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 55. Bluebird Bio Main Business

Table 56. Bluebird Bio Latest Developments

Table 57. Sangamo Details, Company Type, Gene Therapy Area Served and Its Competitors

Table 58. Sangamo Gene Therapy Product Offered

Table 59. Sangamo Main Business

Table 60. Sangamo Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 61. Sangamo Latest Developments

Table 62. Spark Therapeutics Details, Company Type, Gene Therapy Area Served and Its Competitors

Table 63. Spark Therapeutics Gene Therapy Product Offered

Table 64. Spark Therapeutics Main Business

Table 65. Spark Therapeutics Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 66. Spark Therapeutics Latest Developments

Table 67. Dimension Therapeutics Details, Company Type, Gene Therapy Area Served and Its Competitors

Table 68. Dimension Therapeutics Gene Therapy Product Offered

Table 69. Dimension Therapeutics Main Business

Table 70. Dimension Therapeutics Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 71. Dimension Therapeutics Latest Developments

Table 72. Avalanche Bio Details, Company Type, Gene Therapy Area Served and Its Competitors

Table 73. Avalanche Bio Gene Therapy Product Offered

Table 74. Avalanche Bio Main Business

Table 75. Avalanche Bio Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 76. Avalanche Bio Latest Developments

Table 77. Celladon Details, Company Type, Gene Therapy Area Served and Its Competitors

Table 78. Celladon Gene Therapy Product Offered

Table 79. Celladon Main Business

Table 80. Celladon Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 81. Celladon Latest Developments

Table 82. Vical Inc. Details, Company Type, Gene Therapy Area Served and Its Competitors

Table 83. Vical Inc. Gene Therapy Product Offered

Table 84. Vical Inc. Main Business

Table 85. Vical Inc. Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 86. Vical Inc. Latest Developments

Table 87. Advantagene Details, Company Type, Gene Therapy Area Served and Its Competitors

Table 88. Advantagene Gene Therapy Product Offered

Table 89. Advantagene Main Business

Table 90. Advantagene Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 91. Advantagene Latest Developments

List of Figures

Figure 1. Gene Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Gene Therapy Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Gene Therapy Market Size Market Share by Type (2016-2021)

Figure 7. Gene Therapy in Cancer

Figure 8. Global Gene Therapy Market: Cancer (2016-2021) & ($ Millions)

Figure 9. Gene Therapy in Monogenic

Figure 10. Global Gene Therapy Market: Monogenic (2016-2021) & ($ Millions)

Figure 11. Gene Therapy in Infectious Disease

Figure 12. Global Gene Therapy Market: Infectious Disease (2016-2021) & ($ Millions)

Figure 13. Gene Therapy in Cardiovascular Disease

Figure 14. Global Gene Therapy Market: Cardiovascular Disease (2016-2021) & ($ Millions)

Figure 15. Gene Therapy in Other

Figure 16. Global Gene Therapy Market: Other (2016-2021) & ($ Millions)

Figure 17. Global Gene Therapy Market Size Market Share by Application in 2020

Figure 18. Global Gene Therapy Revenue Market Share by Player in 2020

Figure 19. Global Gene Therapy Market Size Market Share by Regions (2016-2021)

Figure 20. Americas Gene Therapy Market Size 2016-2021 ($ Millions)

Figure 21. APAC Gene Therapy Market Size 2016-2021 ($ Millions)

Figure 22. Europe Gene Therapy Market Size 2016-2021 ($ Millions)

Figure 23. Middle East & Africa Gene Therapy Market Size 2016-2021 ($ Millions)

Figure 24. Americas Gene Therapy Market Size Market Share by Country in 2020

Figure 25. Americas Gene Therapy Market Size Market Share by Type in 2020

Figure 26. Americas Gene Therapy Market Size Market Share by Application in 2020

Figure 27. United States Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 28. Canada Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 29. Mexico Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 30. APAC Gene Therapy Market Size Market Share by Regions in 2020

Figure 31. APAC Gene Therapy Market Size Market Share by Type in 2020

Figure 32. APAC Gene Therapy Market Size Market Share by Application in 2020

Figure 33. China Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 34. Japan Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 35. Korea Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 36. Southeast Asia Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 37. India Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 38. Australia Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 39. Europe Gene Therapy Market Size Market Share by Countries in 2020

Figure 40. Europe Gene Therapy Market Size Market Share by Type in 2020

Figure 41. Europe Gene Therapy Market Size Market Share by Application in 2020

Figure 42. Germany Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 43. France Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 44. UK Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 45. Italy Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 46. Russia Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 47. Middle East & Africa Gene Therapy Market Size Market Share by Region in 2020

Figure 48. Middle East & Africa Gene Therapy Market Size Market Share by Type in 2020

Figure 49. Middle East & Africa Gene Therapy Market Size Market Share by Application in 2020

Figure 50. Egypt Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 51. South Africa Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 52. Israel Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 53. Turkey Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 54. GCC Countries Gene Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 55. Americas Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 56. APAC Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 57. Europe Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 58. Middle East & Africa Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 59. United States Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 60. Canada Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 61. Mexico Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 62. Brazil Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 63. China Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 64. Japan Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 65. Korea Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 66. Southeast Asia Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 67. India Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 68. Australia Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 69. Germany Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 70. France Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 71. UK Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 72. Italy Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 73. Russia Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 74. Spain Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 75. Egypt Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 76. South Africa Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 77. Israel Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 78. Turkey Gene Therapy Market Size 2021-2026 ($ Millions)

Figure 79. GCC Countries Gene Therapy Market Size 2021-2026 ($ Millions)